Gencelix

About Us

About Us Hero

About Us

Regenerative medicine therapeutics and treatment technologies
we research and develop.

Gencelix is a bio company that researches and develops advanced bio technologies based on stem cells and immune cells, contributing to better health and quality of life for humanity. In the advanced regenerative medicine field, which is growing rapidly along with national health policy, we provide human cell culture and supply services optimized to the needs of medical institutions. As a trustworthy bio specialist equipped with GMP facilities and strict quality and safety standards, we deliver patient-centered customized cell therapy solutions. As a reliable partner to medical institutions adopting advanced regenerative medicine, we provide total service responsible for the entire process matched to their needs. Building on innovative bio technology and a rigorous certification system, Gencelix moves forward to create a future where more patients benefit from advanced regenerative medicine.

[ History / Agreements ]

  • 2025. 05Gencelix founded
  • 2025. 08Multi-institution MOU signed with Gangnam medical institutions
  • 2025. 10Cell production standard SOP system established
  • 2025. 12Construction started on Clean Room-based GMP production facility
  • 2026. 03GMP facility completed
  • 2026. 04Advanced biopharmaceutical manufacturing approval completed
  • 2026. 09Cell-processing and GMP facility approval completed
  • 2026. 12 (scheduled)Human cell management license expected

Facility infrastructure

Cell Processing Facility

cell processing facility equipped with facilities, equipment, and staff optimized for advanced regenerative medicine institutions, cell processing facility, performing testing and processing of human cells and related materials, responsible for supplying to regenerative medicine institutions.

Cell Culture Room(Cell Culture Room)
Cell Culture Room
Cell Analysis Room(Cell Analysis Room)
Cell Analysis Room
Cell Storage Room(Cell Storage Room)
Cell Storage Room

Vision

“Beyond manufacturing — we build a regenerative medicine ecosystem proven in the clinic.”

Gencelix is not simply a company that makes cells. By organically combining precise GMP production capabilities with a clinical execution network, we accelerate commercialization and global expansion at once so that cell-based therapies can reach real patients' lives — a regenerative medicine platform company. Beyond managing disease symptoms, we are opening a new paradigm of treatment and prevention that addresses fundamental human health problems.

Our Capabilities

① A regenerative medicine standard proven in the clinic A precision manufacturing system on a GMP Clean Room foundation and a standardized SOP·QC quality-control system, connected with the clinical networks of multiple medical institutions. It does not end at manufacturing — we are creating a new standard for cell therapy, validated and accumulated as data in clinical settings.

② Global platform expansion through technology transfer Taking technology transfer and co-development partnerships as our core growth strategy, we expand step by step from the domestic market into the global regenerative medicine market. Gencelix's process design and platform technology are designed to be reproducible anywhere in the world, across borders.

③ Building a one-stop regenerative medicine ecosystem From advanced regenerative medicine designation consulting to treatment hospital registration and cell culture and supply, every process that medical institutions need can be handled with a single partner. As a one-stop solution spanning R&D, manufacturing, and clinical application, we build a sustainable regenerative medicine ecosystem that grows together with medical institutions.

Gencelix's Promise for the Future

Regenerative medicine is no longer technology for the few. Through innovative stem cell and immune cell technologies and a rigorous clinical verification structure, Gencelix builds a world where more patients can genuinely enjoy the benefits of advanced regenerative medicine. Our vision goes beyond establishing leadership in the global bio market — it opens a sustainable future for the healthy lives of humanity.

“Gencelix puts the future of humanity into every single cell — every single day.”

vision_image

Medical Staff

The Gencelix medical advisory board is composed of physicians from each specialized field, and enhances the credibility of our research and business through expert consultation.

Internal MedicineKim Cheol-su
PsychiatryKim Jeong-min
Otolaryngology (ENT)Lee Won-yong
NeurologyPark Jae-hyun, Kim Baek-kyun
OphthalmologyKim Seon-young
DentistryKim Jin-beom
Emergency MedicineTBD
OtherKim Seung-jin
General SurgeryAhn Young-ju
OrthopedicsSeo Won-young, Lee Seung-yeop
DermatologyKang Seung-hoon, Kim Ki-hoon
Family MedicineKim Ju-hee
Anesthesiology and Pain MedicinePark Seok-jeong
NeurosurgeryTBD
Pediatrics and Adolescent MedicineTBD
Obstetrics and GynecologyJeon Dong-su, Lee Dong-hee
Plastic SurgeryKim Hyeong-seok, Kim Hyeong-rok, Lee Young-taek, Do Eon-rok
UrologyJo Seung-hoon
Laboratory MedicineYoo Shin-ae
Rehabilitation MedicinePark Dong-hwi
Radiation OncologyTBD
Korean MedicineTBD